Product Information
RELPAX 20 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $78.1117 per EA under NDC 58151036756. Its NADAC has been published 51 times since Jul 9, 2025.
Strength
20 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151036756
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ELETRIPTAN HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021016On Market Since
5/8/2025
Pharmacological Classes
Price Statistics
The NADAC for RELPAX 20 MG TABLET has been published 51 times since Jul 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $78.1117 per EA |
|---|---|
| All-time high | $78.1117 (Jun 24, 2026) |
| All-time low | $77.1903 (May 20, 2026) |
| 52-week high | $78.1117 |
| 52-week low | $77.1903 |
| Median price | $77.5717 |
| Average price | $77.5337 |
| Largest weekly change | +1.2% (Jun 17, 2026) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RELPAX 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RELPAX 20 MG TABLET, manufactured by Viatris Specialty LLC, is $78.1117 per EA (NDC 58151036756), effective Jun 24, 2026.
How has the price of RELPAX 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for RELPAX 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for RELPAX 20 MG TABLET?
Since Jul 9, 2025, the NADAC for RELPAX 20 MG TABLET has ranged from a low of $77.1903 (May 20, 2026) to a high of $78.1117 (Jun 24, 2026), with a median of $77.5717 per EA.
Are there cheaper alternatives to RELPAX 20 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ELETRIPTAN HBR 20 MG TABLET, is $2.2619 per EA — about 97% below RELPAX 20 MG TABLET.
Who manufactures RELPAX 20 MG TABLET?
RELPAX 20 MG TABLET (NDC 58151036756) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification